Food allergy affects 8% of US children, and about a third of food-allergic children have more than one food allergy. These ...

A very low peanut oral immunotherapy (P-OIT) maintenance dose of 30 mg significantly increased reaction thresholds for ...

Late-onset asthma risk is associated with numerous lifestyle-related metabolites, particularly among women, according to study findings published in The Journal of Allergy and Clinical Immunology.

Sanofi and Regeneron’s Dupixent approved as the first targeted medicine in the EU in over a decade for chronic spontaneous urticaria Approval ...

EoE is increasingly diagnosed in Europe, yet for many patients, the biggest hurdle lies beyond treating the inflammation.

Allergen starter kits promise to make introducing foods to babies easier, but experts are concerned they may not be effective.

BIIB's research deal with Dayra targets oral macrocyclic peptides to advance its immunology pipeline and expand ...

An injection that blocks the activity of a protein involved in aging reverses naturally occurring cartilage loss in the knee ...

Live webcasts of the fireside chats will be available on the investor section of the Anaptys website at https://ir.anaptysbio.com/presentations-and-events. Replays of the webcasts will be available ...

Highlighting 10 innovative late-stage BioPharma drugs with the potential to reshape treatment paradigms and industry dynamics ...

A brutal 90% single-day crash and a shareholder’s full exit raise the stakes for MoonLake’s upcoming FDA meeting.

Knowledge of biologic use in pediatric patients with asthma improved among pulmonologists, allergists/immunologists and ...